Two climatetech startups are joining a new program from Greentown Labs and Browning the Green Space. Photo via greentownlabs.com

A new accelerator focused on BIPOC-led energy tech startups named its inaugural cohort, and two Houston-based companies made the cut.

The new program — Advancing Climatetech and Clean Energy Leaders Program, or ACCEL — is an initiative led by Greentown Labs and Browning the Green Space that was originally announced in November. The program was established to provide access to funding, networking connections, resources, and more to BIPOC-led startups working on a climatetech solution.

The program is supported by the Massachusetts Clean Energy Center, or MassCEC, a state economic development agency, and the Boston-based Barr Foundation, a Boston-based foundation. Each of the selected startups will receive a $25,000 grant, incubation at Greentown, mentorship from Greentown and BGS’s networks, and access to a curriculum curated by VentureWell, a nonprofit with deep expertise in the climatetech space.

“We are thrilled and eager to support this exceptional cohort of startup leaders as they tackle some of our world’s biggest climate challenges,” says Kevin T. Taylor, CFO and interim CEO at Greentown Labs, in a news release. “Through partnerships with Browning the Green Space and VentureWell—and with the support from MassCEC and the Barr Foundation—we look forward to offering intentional mentorship, training, and networking opportunities to help these BIPOC-led startups thrive.”

The co-located program will host startups at each of the two Greentown Labs locations in the Houston and Boston areas. The inaugural cohort includes:

  • Active Surfaces, based in Salem, Massachusetts, unlocks dual land-use applications through its ultra-thin-film, flexible solar technology. Its co-founders are Shivam Bhakta and Richard Swartwout.
  • Houston-based DrinKicks is a sneaker-themed consumer-products company that is focused on repurposing food waste and recycled materials into sustainable goods such as shoes, sports equipment, and clothing, all while educating consumers on the power of the circular economy. The company was co-founded by Kristeen Reynolds, Michael Fletcher, and Kristen Lee.
  • EarthBond, headquartered in Cambridge, Massachusetts, leverages group financing and carbon accounting to lower costs and risk in the energy transition of Nigeria's $14B fuel-based, off-grid generator market. Chidalu Onyenso founded the business.
  • Amherst, Massachusetts-based florrent is a bio-based materials and energy storage company providing solutions to address critical bottlenecks to the global decarbonization and electrification of utilities, transportation, and buildings. Its co-founders are Jose LaSalle, Joe Hastry, and Alexander Nichols. florrent is a current Greentown member.
  • frakktal, founded in Houston by Jhana Porter, is a B2B materials company developing bio-based polymer processes for the replacement of fossil-fuel-based feedstocks across industries. The company is a current Greentown member.
  • SpadXTech from Worcester, Massachusetts, is contributing to the reduction of CO2 emissions impacting several industries such as packaging, textiles, transportation, filtration, and construction through the manufacturing of its core and versatile material platform technology. Its co-founders are Lina M. González and Connor Crawford.

“We are inspired by and excited to support the wealth of innovation and fresh perspectives on climate solutions offered by our inaugural ACCEL cohort of startup leaders,” said Kerry Bowie, executive director and president of Browning the Green Space. “Through this partnership with Greentown Labs we are able to build critical support infrastructure for entrepreneurs of color and accelerate the equitable development and distribution of climate solutions across all communities.”

The program will officially kick off at an event on February 23 at Greentown’s Boston location.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston clean hydrogen startup to pilot tech with O&G co.

stay gold

Gold H2, a Houston-based producer of clean hydrogen, is teaming up with a major U.S.-based oil and gas company as the first step in launching a 12-month series of pilot projects.

The tentative agreement with the unnamed oil and gas company kicks off the availability of the startup’s Black 2 Gold microbial technology. The technology underpins the startup’s biotech process for converting crude oil into proprietary Gold Hydrogen.

The cleantech startup plans to sign up several oil and gas companies for the pilot program. Gold H2 says it’s been in discussions with companies in North America, Latin America, India, Eastern Europe and the Middle East.

The pilot program is aimed at demonstrating how Gold H2’s technology can transform old oil wells into hydrogen-generating assets. Gold H2, a spinout of Houston-based biotech company Cemvita, says the technology is capable of producing hydrogen that’s cheaper and cleaner than ever before.

“This business model will reshape the traditional oil and gas industry landscape by further accelerating the clean energy transition and creating new economic opportunities in areas that were previously dismissed as unviable,” Gold H2 says in a news release.

The start of the Black 2 Gold demonstrations follows the recent hiring of oil and gas industry veteran Prabhdeep Singh Sekhon as CEO.

“With the proliferation of AI, growth of data centers, and a national boom in industrial manufacturing underway, affordable … carbon-free energy is more paramount than ever,” says Rayyan Islam, co-founder and general partner at venture capital firm 8090 Industries, an investor in Gold H2. “We’re investing in Gold H2, as we know they’ll play a pivotal role in unleashing a new dawn for energy abundance in partnership with the oil industry.”

------

This article originally ran on EnergyCapital.

3 Houston innovators to know this week

who's who

Editor's note: Every week, I introduce you to a handful of Houston innovators to know recently making headlines with news of innovative technology, investment activity, and more. This week's batch includes an e-commerce startup founder, an industrial biologist, and a cellular scientist.

Omair Tariq, co-founder and CEO of Cart.com

Omair Tariq of Cart.com joins the Houston Innovators Podcast to share his confidence in Houston as the right place to scale his unicorn. Photo via Cart.com

Houston-based Cart.com, which operates a multichannel commerce platform, has secured $105 million in debt refinancing from investment manager BlackRock.

The debt refinancing follows a recent $25 million series C extension round, bringing Cart.com’s series C total to $85 million. The scaleup’s valuation now stands at $1.2 billion, making it one of the few $1 billion-plus “unicorns” in the Houston area.

Cart.com was co-founded by CEO Omair Tariq in October 2020. Read more.

Nádia Skorupa Parachin, vice president of industrial biotechnology at Cemvita

Nádia Skorupa Parachin joined Cemvita as vice president of industrial biotechnology. Photo courtesy of Cemvita

Houston-based biotech company Cemvita recently tapped two executives to help commercialize its sustainable fuel made from carbon waste.

Nádia Skorupa Parachin came aboard as vice president of industrial biotechnology, and Phil Garcia was promoted to vice president of commercialization.

Parachin most recently oversaw several projects at Boston-based biotech company Ginkjo Bioworks. She previously co-founded Brazilian biotech startup Integra Bioprocessos. Read more.

Han Xiao, associate professor of chemistry at Rice University

The funds were awarded to Han Xiao, a chemist at Rice University.

A Rice University chemist has landed a $2 million grant from the National Institute of Health for his work that aims to reprogram the genetic code and explore the role certain cells play in causing diseases like cancer and neurological disorders.

The funds were awarded to Han Xiao, the Norman Hackerman-Welch Young Investigator, associate professor of chemistry, from the NIH's Maximizing Investigators’ Research Award (MIRA) program, which supports medically focused laboratories. Xiao will use the five-year grant to advance his work on noncanonical amino acids.

“This innovative approach could revolutionize how we understand and control cellular functions,” Xiao said in the statement. Read more.

Houston chemist lands $2M NIH grant for cancer treatment research

future of cellular health

A Rice University chemist has landed a $2 million grant from the National Institute of Health for his work that aims to reprogram the genetic code and explore the role certain cells play in causing diseases like cancer and neurological disorders.

The funds were awarded to Han Xiao, the Norman Hackerman-Welch Young Investigator, associate professor of chemistry, from the NIH's Maximizing Investigators’ Research Award (MIRA) program, which supports medically focused laboratories.

Xiao will use the five-year grant to develop noncanonical amino acids (ncAAs) with diverse properties to help build proteins, according to a statement from Rice. He and his team will then use the ncAAs to explore the vivo sensors for enzymes involved in posttranslational modifications (PTMs), which play a role in the development of cancers and neurological disorders. Additionally, the team will look to develop a way to detect these enzymes in living organisms in real-time rather than in a lab.

“This innovative approach could revolutionize how we understand and control cellular functions,” Xiao said in the statement.

According to Rice, these developments could have major implications for the way diseases are treated, specifically for epigenetic inhibitors that are used to treat cancer.

Xiao helped lead the charge to launch Rice's new Synthesis X Center this spring. The center, which was born out of informal meetings between Xio's lab and others from the Baylor College of Medicine’s Dan L Duncan Comprehensive Cancer Center at the Baylor College of Medicine, aims to improve cancer outcomes by turning fundamental research into clinical applications.

They will build upon annual retreats, in which investigators can share unpublished findings, and also plan to host a national conference, the first slated for this fall titled "Synthetic Innovations Towards a Cure for Cancer.”